BRCA1 and cancer: Combined the finding that 83.5% of HGSOC in our study were satisfied/highly satisfied with having reflex BRCA1/2 tumour genetic testing completed as part of their cancer care, available data suggest gaps in knowledge about tumour genetic testing may be of minimal concern for cancer patients.